These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16014879)

  • 21. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant use of nesiritide and milrinone in decompensated congestive heart failure.
    Smull DL; Jorde UP
    Am J Health Syst Pharm; 2005 Feb; 62(3):291-5. PubMed ID: 15719588
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.
    Abraham WT; Cheng ML; Smoluk G;
    Congest Heart Fail; 2005; 11(2):59-64. PubMed ID: 15860969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of nesiritide to treat acute decompensated heart failure.
    Hachey DM; Smith T
    Crit Care Nurse; 2003 Feb; 23(1):53-5. PubMed ID: 12640959
    [No Abstract]   [Full Text] [Related]  

  • 25. Nesiritide vs nitroglycerin for decompensated congestive heart failure.
    Dunavant S
    JAMA; 2002 Aug; 288(5):571-2; author reply 572-3. PubMed ID: 12150661
    [No Abstract]   [Full Text] [Related]  

  • 26. Nesiritide in acute heart failure.
    Drazner M; McGuire DK; de Lemos JA
    Lancet; 2003 Sep; 362(9388):998-9. PubMed ID: 14511940
    [No Abstract]   [Full Text] [Related]  

  • 27. BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential.
    Burger MR; Burger AJ
    Curr Opin Investig Drugs; 2001 Jul; 2(7):929-35. PubMed ID: 11757793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of nesiritide for the treatment of decompensated heart failure.
    Emerman CL
    Rev Cardiovasc Med; 2002; 3 Suppl 4():S28-34. PubMed ID: 12439428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of death associated with nesiritide in patients with acutely decompensated heart failure.
    Aaronson KD; Sackner-Bernstein J
    JAMA; 2006 Sep; 296(12):1465-6. PubMed ID: 17003394
    [No Abstract]   [Full Text] [Related]  

  • 30. Nesiritide: harmful or harmless?
    Dorsch MP; Rodgers JE
    Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Observation unit treatment of heart failure with nesiritide: results from the proaction trial.
    Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL
    J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of a large nesiritide bolus dose in a pediatric patient: case report and review of nesiritide use in pediatrics.
    Moffett BS; Jefferies JL; Price JF; Clunie S; Denfield S; Dreyer WJ; Towbin JA
    Pharmacotherapy; 2006 Feb; 26(2):277-80. PubMed ID: 16466333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of nesiritide on renal function and mortality in patients suffering from heart failure.
    Dontas ID; Xanthos T; Dontas I; Lelovas P; Papadimitriou L
    Cardiovasc Drugs Ther; 2009 Jun; 23(3):221-33. PubMed ID: 19252976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nesiritide: the clinical experience.
    Weeks SG
    Can J Cardiol; 2008 Jul; 24 Suppl B(Suppl B):19B-21B. PubMed ID: 18629384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous nesiritide in acute heart failure.
    Knox MA; Dancy T; Mook W; Pschirer JJ
    Am J Ther; 2005; 12(3):233-7. PubMed ID: 15891267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nesiritide speeds recovery time for heart failure patients.
    Morrow T
    Manag Care; 2004 Jul; 13(7):60-1. PubMed ID: 15347161
    [No Abstract]   [Full Text] [Related]  

  • 37. Vasodilators in the management of acute heart failure.
    Elkayam U; Janmohamed M; Habib M; Hatamizadeh P
    Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain natriuretic peptide: a diagnostic and treatment hormone for perioperative congestive heart failure.
    Skidmore KL; Russell IA
    J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):780-7. PubMed ID: 15650995
    [No Abstract]   [Full Text] [Related]  

  • 39. Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure.
    Ma X; Sun F; Ma J
    Int J Cardiol; 2015; 187():387-8. PubMed ID: 25841132
    [No Abstract]   [Full Text] [Related]  

  • 40. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
    Mehra MR; McCluskey T; Barr M; Bourge RC; Jessup ML; Mancini D; Radovancevic B; Rayburn B; Taylor DO; Lilly-Hersley J; Linde P
    Am Heart J; 2007 Jun; 153(6):932-40. PubMed ID: 17540193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.